WIRE vs. BMY

Last updated Apr 1, 2026

Compare and contrast key facts about Encore Wire Corporation (WIRE) and Bristol-Myers Squibb Company (BMY).

Performance

WIRE vs. BMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Encore Wire Corporation (WIRE) and Bristol-Myers Squibb Company (BMY). The values are adjusted to include any dividend payments, if applicable.

WIRE vs. BMY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
WIRE Encore Wire Corporation	0.00%	0.00%	35.72%	55.35%	-3.81%	136.44%	5.74%	14.55%	3.31%	12.43%
BMY Bristol-Myers Squibb Company	13.77%	0.11%	15.81%	-26.14%	18.98%	2.88%	0.41%	27.74%	-12.90%	7.71%

Fundamentals

Total Revenue (TTM) WIRE : $2.54B BMY : $48.19B
Gross Profit (TTM) WIRE : $586.79M BMY : $30.43B
EBITDA (TTM) WIRE : $412.78M BMY : $13.82B

Returns By Period

WIRE

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

BMY

• 1D: 1.54%
• 1M: -2.76%
• YTD: 13.77%
• 6M: 37.94%
• 1Y: 4.47%
• 3Y*: 0.11%
• 5Y*: 3.12%
• 10Y*: 2.72%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

WIRE vs. BMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMY

BMY Risk / Return Rank: 45
BMY Sharpe Ratio Rank: 48
BMY Sortino Ratio Rank: 41
BMY Omega Ratio Rank: 40
BMY Calmar Ratio Rank: 48
BMY Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WIRE vs. BMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Encore Wire Corporation (WIRE) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	WIRE	BMY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.16	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.13	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.11	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.35	—

Correlation

The correlation between WIRE and BMY is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WIRE vs. BMY - Dividend Comparison

WIRE has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.11%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
WIRE Encore Wire Corporation	0.00%	0.00%	0.01%	0.04%	0.06%	0.04%	0.17%	0.14%	0.16%	0.16%	0.18%	0.16%
BMY Bristol-Myers Squibb Company	4.11%	4.60%	4.24%	4.44%	3.00%	2.36%	3.69%	2.55%	3.08%	2.55%	1.95%	2.17%

Drawdowns

Drawdown Indicators

	WIRE	BMY	Difference
Max Drawdown Largest peak-to-trough decline	—	-72.03%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-25.79%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-47.67%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-47.67%	—
Current Drawdown Current decline from peak	—	-13.61%	—
Average Drawdown Average peak-to-trough decline	—	-22.40%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	17.63%	—

Volatility

Volatility by Period

	WIRE	BMY	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.67%	—
Volatility (6M) Calculated over the trailing 6-month period	—	19.42%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	28.60%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	23.66%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	25.08%	—

Financials